PT64885B - Method for preparing 17alpha-ester-21-halopregnanes - Google Patents

Method for preparing 17alpha-ester-21-halopregnanes

Info

Publication number
PT64885B
PT64885B PT64885A PT6488576A PT64885B PT 64885 B PT64885 B PT 64885B PT 64885 A PT64885 A PT 64885A PT 6488576 A PT6488576 A PT 6488576A PT 64885 B PT64885 B PT 64885B
Authority
PT
Portugal
Prior art keywords
halopregnanes
ester
17alpha
preparing
preparing 17alpha
Prior art date
Application number
PT64885A
Other languages
English (en)
Portuguese (pt)
Other versions
PT64885A (en
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50038914A external-priority patent/JPS51125372A/ja
Priority claimed from JP50052085A external-priority patent/JPS51128954A/ja
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of PT64885A publication Critical patent/PT64885A/pt
Publication of PT64885B publication Critical patent/PT64885B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT64885A 1975-03-31 1976-03-10 Method for preparing 17alpha-ester-21-halopregnanes PT64885B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50038914A JPS51125372A (en) 1975-03-31 1975-03-31 Aprocess for preparing pregnane steroid-17-ester-21-halides
JP50052085A JPS51128954A (en) 1975-05-01 1975-05-01 Process for preparing 17-ester-21-halides of pregnate type s teroids

Publications (2)

Publication Number Publication Date
PT64885A PT64885A (en) 1976-04-01
PT64885B true PT64885B (en) 1977-11-17

Family

ID=26378215

Family Applications (1)

Application Number Title Priority Date Filing Date
PT64885A PT64885B (en) 1975-03-31 1976-03-10 Method for preparing 17alpha-ester-21-halopregnanes

Country Status (14)

Country Link
US (1) US4113680A (US07223432-20070529-C00017.png)
CA (1) CA1044225A (US07223432-20070529-C00017.png)
CH (1) CH609709A5 (US07223432-20070529-C00017.png)
DE (1) DE2613875A1 (US07223432-20070529-C00017.png)
DK (1) DK141171B (US07223432-20070529-C00017.png)
ES (1) ES446411A1 (US07223432-20070529-C00017.png)
FR (1) FR2306214A1 (US07223432-20070529-C00017.png)
GB (1) GB1508517A (US07223432-20070529-C00017.png)
HU (1) HU174850B (US07223432-20070529-C00017.png)
IN (1) IN142583B (US07223432-20070529-C00017.png)
NL (1) NL7603249A (US07223432-20070529-C00017.png)
PT (1) PT64885B (US07223432-20070529-C00017.png)
SE (1) SE403380B (US07223432-20070529-C00017.png)
YU (1) YU54476A (US07223432-20070529-C00017.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2742982C2 (de) * 1977-09-21 1985-12-12 Schering AG, 1000 Berlin und 4709 Bergkamen 9-Chlorprednisolon-Derivate, Verfahren zu deren Herstellung und diese enthaltendes pharmazeutisches Präparat
DE2817988A1 (de) * 1978-04-25 1979-11-08 Hoechst Ag Corticoid 17-alkylcarbonate und verfahren zu deren herstellung
US4361558A (en) * 1980-04-29 1982-11-30 Ciba-Geigy Corporation Halogenated steroids
US4440689A (en) * 1981-07-22 1984-04-03 Mitsubishi Chemical Industries, Limited Acyloxysteroids and process for producing same
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
DE3915951C1 (US07223432-20070529-C00017.png) * 1989-05-12 1990-09-13 Schering Ag, 1000 Berlin Und 4709 Bergkamen, De
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
DK1305329T4 (da) * 2000-08-05 2015-06-15 Glaxo Group Ltd 6alpha, 9alpha-difluor-17alpha-(2-furanylcarboxyl)oxy-11beta-hydroxy-16alpha-methyl-3-oxo-androst-1,4-dien-17-carbothiosyre-S-fluormethylester som et antiinflammatorisk middel
PL366937A1 (en) * 2001-04-30 2005-02-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
AU2002356759A1 (en) * 2001-12-01 2003-06-17 Glaxo Group Limited 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7208485B2 (en) * 2003-01-13 2007-04-24 Chemagis Ltd. Crystalline forms of halobetasol propionate
US20040138192A1 (en) * 2003-01-13 2004-07-15 Chemagis Ltd. Crystalline forms of halobetasol propionate
AT501376B1 (de) * 2005-01-17 2010-11-15 Pregenzer Bruno Glucokortikoid-hältiges arzneimittel
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN109608511B (zh) * 2019-01-24 2021-05-04 上海新华联制药有限公司 泼尼松龙醋酸戊酸酯的化学合成工艺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE373332C (sv) * 1972-02-25 1977-07-25 Centralsug Ab Anordning for utvinning av fibermaterial ur blandat gods
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
CH609709A5 (US07223432-20070529-C00017.png) 1979-03-15
YU54476A (en) 1982-05-31
US4113680A (en) 1978-09-12
IN142583B (US07223432-20070529-C00017.png) 1977-07-30
FR2306214B1 (US07223432-20070529-C00017.png) 1981-04-30
ES446411A1 (es) 1979-02-01
DK141171C (US07223432-20070529-C00017.png) 1980-07-07
SE403380B (sv) 1978-08-14
GB1508517A (en) 1978-04-26
NL7603249A (nl) 1976-10-04
DK144076A (US07223432-20070529-C00017.png) 1976-10-01
SE7603791L (sv) 1976-10-01
PT64885A (en) 1976-04-01
CA1044225A (en) 1978-12-12
FR2306214A1 (fr) 1976-10-29
DE2613875A1 (de) 1976-10-14
DK141171B (da) 1980-01-28
HU174850B (hu) 1980-03-28

Similar Documents

Publication Publication Date Title
HU174396B (hu) Sposob poluchenija 17-al'fa-gidroksi-kortikosteroidov
JPS527943A (en) Process for preparing same
PT64885B (en) Method for preparing 17alpha-ester-21-halopregnanes
JPS5273833A (en) Process for preparing orthoo hydroxyarylaldehyde
GB1548032A (en) Process for preparing amono-acid admides
CS191310B2 (en) Process for preparing 11-deoxy-16-aryloxy-omega-tetranorprostaglandines
HU175022B (hu) Sposob poluchenija 11-deoksi-acetilen-aril-prostaglandinov
JPS5239608A (en) Process for preparing perfluoroalkyliodide teromer
YU208176A (en) Process for preparing n-tetrahydrofurfuryl-nor-oximorphones
HU172964B (hu) Sposob poluchenija n-aril-n-/1-l-4-piperidinil/-aril-acetamidov
JPS52233A (en) Process for preparing paraaalkylphenol
HU174650B (hu) Sposob poluchenija l-piroglutamil-l-prolinamida
JPS5273803A (en) Process for preparing halogenoalkene
GB1542488A (en) Process for preparing alpha-amino-gamma-methylmercaptobutyronitrile
JPS51115453A (en) Process for preparing 22naphtylaminee 11sulphonate
HU174888B (hu) Sposob poluchenija 1-naftil-n-metil-karbamata
JPS51125467A (en) Process for preparing graftcopolymer
HU175729B (hu) Sposob poluchenija ftoroprostaglandinov
HU174777B (hu) Sposob poluchenija 2-acilamino-oksazolov
JPS5210202A (en) Process for preparing c2hydrocarbon
GB1543929A (en) Process for preparing dihalovinylcyclopropane-carboxylates
HU174667B (hu) Sposob poluchenija omega-amino-alkankarbonil-aril-amidov
HU174633B (hu) Sposob poluchenija glikolal'degida
EG12462A (en) Process for preparing imidazolobenzodiazepines
YU215176A (en) Process for preparing phenyl-ureas